中华神经外科杂志
中華神經外科雜誌
중화신경외과잡지
Chinese Journal of Neurosurgery
2011年
2期
125-130
,共6页
李冬雪%牛朝诗%刘于海%李静%汤深凤%傅先明
李鼕雪%牛朝詩%劉于海%李靜%湯深鳳%傅先明
리동설%우조시%류우해%리정%탕심봉%부선명
神经胶质瘤%基因表达%Nanog%肿瘤干细胞
神經膠質瘤%基因錶達%Nanog%腫瘤榦細胞
신경효질류%기인표체%Nanog%종류간세포
Glioma%Gene expression%Nanog%Cancer stem cell
目的 探讨Nanog基因在脑肿瘤干细胞(BTSCs)的表达以及生物学意义.方法 无血清悬浮培养法从U87胶质瘤细胞株分离培养BTSCs.免疫细胞化学染色和RT-PCR方法检测U87肿瘤细胞及其BTSCs中Nanog的表达,双重免疫细胞化学染色法检测Nanog/CD133共表达情况.结果 在U87胶质瘤细胞株中成功分离培养出BTSCs,Nanog蛋白在U87肿瘤细胞和BTSCs中的阳性率分别为(64.1±18.2)%和(97.2±1.8)%,且Nanog+/CD133+细胞共表达于部分细胞中;Nanog mRNA相对含量在U87肿瘤细胞和BTSCs中分别为0.3851±0.0771和0.6032±0.1223,差异有统计学意义(P<0.05).结论 U87细胞株中存在BTSCs.Nanog在U87细胞株中高表达,在BTSCs中表达水平高于U87肿瘤细胞且Nanog与CD133存在共表达,表明Nanog与BTSCs关系密切.
目的 探討Nanog基因在腦腫瘤榦細胞(BTSCs)的錶達以及生物學意義.方法 無血清懸浮培養法從U87膠質瘤細胞株分離培養BTSCs.免疫細胞化學染色和RT-PCR方法檢測U87腫瘤細胞及其BTSCs中Nanog的錶達,雙重免疫細胞化學染色法檢測Nanog/CD133共錶達情況.結果 在U87膠質瘤細胞株中成功分離培養齣BTSCs,Nanog蛋白在U87腫瘤細胞和BTSCs中的暘性率分彆為(64.1±18.2)%和(97.2±1.8)%,且Nanog+/CD133+細胞共錶達于部分細胞中;Nanog mRNA相對含量在U87腫瘤細胞和BTSCs中分彆為0.3851±0.0771和0.6032±0.1223,差異有統計學意義(P<0.05).結論 U87細胞株中存在BTSCs.Nanog在U87細胞株中高錶達,在BTSCs中錶達水平高于U87腫瘤細胞且Nanog與CD133存在共錶達,錶明Nanog與BTSCs關繫密切.
목적 탐토Nanog기인재뇌종류간세포(BTSCs)적표체이급생물학의의.방법 무혈청현부배양법종U87효질류세포주분리배양BTSCs.면역세포화학염색화RT-PCR방법검측U87종류세포급기BTSCs중Nanog적표체,쌍중면역세포화학염색법검측Nanog/CD133공표체정황.결과 재U87효질류세포주중성공분리배양출BTSCs,Nanog단백재U87종류세포화BTSCs중적양성솔분별위(64.1±18.2)%화(97.2±1.8)%,차Nanog+/CD133+세포공표체우부분세포중;Nanog mRNA상대함량재U87종류세포화BTSCs중분별위0.3851±0.0771화0.6032±0.1223,차이유통계학의의(P<0.05).결론 U87세포주중존재BTSCs.Nanog재U87세포주중고표체,재BTSCs중표체수평고우U87종류세포차Nanog여CD133존재공표체,표명Nanog여BTSCs관계밀절.
Objective To detect the expression of Nanog in glioma cell line U87 and the relationship with BTSCs.Methods BTSCs were isolated from glioma cell line U87 and cultured in simplified serum-free neural stem cell medium by nanosphere suspension culture method spheres,and purified continuously through the monoclonal formation experiment.The immunofluorescence staining of cells was employed to identify the BTSCs and differentiated cells.The expression of Nanog mRNA was examined by RT- PCR and Nanog protein was detected by immunocytochemistry in U87 and BTSCs respectively.Double immunocytochemistry staining was used to detect the co- expressions of Nanog/CD133.Methods BTSCs were isolated ,cultured and purified successfully from glioma cell line U87.Both Nanog mRNA and protein were expressed in U87 and BTSCs.The expression rate of immunopositive cells was (64.1 ±18.2)% in U87 and (97.2±1.8)% in BTSCs respectively(t =5.719,P =0.000).The Nanog+/CD133+ cells could be found co-expressed in U87 and BTSCs by using double immunocytochemistry s taining.The relative level of Nanog expression was 0.3851 ±0.0771 in U87 and0.6032±0.1223 in BTSCs(t =4.770,P =0.000).Conclusion BTSCs exist in glioma cell line U87 in vitro.The levels of Nanog expression in BTSCs were higher than that in U87.Nanog expression was associated with the genesis and differentiation state of glioma.The overexpression of Nanog and co- expression of Nanog/CD133 showed that it might contribute to the existence of BTSCs,which lay a foundation to the further explore its role in biological behaviour of glioma.Expression of Nanog in U87 indicated the close relationship between glioma and stem cell,and suggested Nanog may play a critical role in the development of glioma.